Marco D'Agata

Marco D'Agata Email and Phone Number

CEO and Founder @ Neolook Solutions
Utrecht, UT, NL
Marco D'Agata's Location
Hilversum, North Holland, Netherlands, Netherlands
Marco D'Agata's Contact Details

Marco D'Agata personal email

About Marco D'Agata

Opens doors that remain closed to most of us.Makes the unsuspected, the unlikely happen.

Marco D'Agata's Current Company Details
Neolook Solutions

Neolook Solutions

View
CEO and Founder
Utrecht, UT, NL
Employees:
15
Marco D'Agata Work Experience Details
  • Neolook Solutions
    Ceo And Founder
    Neolook Solutions
    Utrecht, Ut, Nl
  • Neolook Solutions
    Ceo & Founder
    Neolook Solutions Jan 2020 - Present
    Utrecht, Netherlands
    ✭✭✭ Winner Life Science Innovation Award 2024✭✭✭ Honorable visit to Máxima MC by his majesty King Willem Alexander of the Netherlands✭✭✭ Finalist National Healthcare Innovation Award 2024✭✭✭ Qualio Winner Catalyst Life Science Award (global)✭✭✭ 1st Place Dutch Computable Awards 2023 ('Oscar of IT awards in NL')✭✭✭ Featured in De Medisch Specialist 2022 (30.000 copies)✭✭✭ Finalist Dutch Student Innovation Award 2022 (115 submissions)✭✭✭ Winner EU Bridgehead 2021✭✭✭ Finalist UK Healthtech Awards 2021✭✭✭ Featured Dutch AD newspaper, Tokyo News TVMedical grade video services for love, attention and clinical understanding in neonatal and pediatric intensive careS2S Family - Watch your newborn in the NICU from home, share live with partner, sibs and extended family. Simple, Secure and Safe with privacy by design (EU standards).S2S Academic - Extend to academic research, develop clinical algorithms and AI. S2S Professional - Line of Sight, Alarm mgt, Event Capture, Remote Consultation, Integrations.With add-ons: Neolook One smart sensor, Cry Detection, Benefit Tracking, EarlyMoves.explore https://www.neolooksolutions.com
  • Philips
    Senior Strategic Business Architect Emea
    Philips Aug 2015 - Dec 2019
    Netherlands
    ✭✭✭ "One of the coolest jobs in Philips" - Human Resources✭✭✭ Fatebenefratelli NICU solution on TG1 national news in Italy✭✭✭ NICU Solution in Dutch newspaper of record NRC, two page background articleI. Team Lead of Strategic Business Architects EMEA/LATAM Lead of Strategic Business Architects global community of practiceII. Lead the solution design of complex, innovative solutions covering the full continuum of care, using Value Based Care and Philips Quadrupal Aim. Grow Philips integrated solutions business. Drive the creation of groundbreaking solutions in Europe, the Middle East, Africa and Latin America. Realize first-of-a-kind deals and make replicable elsewhere.With a peculiar focus on Value Based Care (#VBC), Philips' Quadrupal Aim, the clinical perspective and #reimbursement.III. Bring together and grow the Strategic Business Architect Community in markets worldwide. With high quality solutions content, develop and share best practices, on the fly cross-market learning on deals as they happen, with the aim of global professionalization and scalability.Example Solutions / Longterm Strategic Partnerships- Neonatal Intensive Care Unit (NICU) modernization in Italy (National News TV, NRC)- Design of healthcare ecosystem at regional scale in Nordics- Ring of sustainable referral hospitals at national scale in Africa- Medical City with data analytics, data science and adaptive intelligence in Middle EastRoyal Philips is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.
  • Achmea
    Senior Strategy And Policy Deployment For High Cost Medicine
    Achmea Apr 2012 - Aug 2015
    Leiden
    ✭✭✭ 2018 Hospital made high cost medicines - national TV 8 o’clock news, NOS✭✭✭ 2015, 2018 Initatiefgroep Biosimilars Nederland - national TV news, NOS✭✭✭ 2014 Impact Collective Farma - national 8 o'clock TV news, frontpage FD, NOSAchmea, the nr 1 healthcare insurer, covers 30% of the population and contracts EUR 700-900 million of specialty pharmacy a year. A dedicated team was set up to anticipate major shifts and prevent high cost medicines (biologicals) spiralling out of control. Thereby safeguarding solidarity, sustainable affordable care and access for all. Achievements 2012-2015I. Impact Collective FarmaDesign and introduction of a formerly unseen market mechanism for group procurement (gezamenlijke inkoop) of high cost medicines. The collective was formed by 20 hospitals and Achmea adding up to 30-35% of the national volume. Benefits are shared in three thirds to hospitals, consumers and an innovation agenda. IC Farma deeply impacted and transformed the national market landscape of EUR 1,5 billion annualy.II. Initatiefgroep Biosimilars Nederland (IBN)Design and introduction of a novel scheme to further the uptake of biosimilars: IBN is a content and knowledge driven group to develop and disseminate key knowledge, educate professionals and public, and challenge policies and standpoints. IBN was designed in 2013, started in 2014 and had it’s first national symposium in september 2015.III. Hospital made high cost medicinesSeven key farma innovations were selected in an overarching disruption framework and funneled to market. The aim is a supply chain that is end-user driven and responsive to societal needs. The seven included 25% dose reduction, biosimilars, MedEye, and deep impact ones like hospital production of Rhenium, biologicals recycling and the seminal realisation of ‘short chain pharma' for hospital production of orphan drugs: magistrale bereiding with AMC.
  • Dutch Institute For Rational Use Of Medicine
    Senior Innovation, Acquisition, And Market Development
    Dutch Institute For Rational Use Of Medicine Jan 2003 - Jun 2012
    Utrecht Area, Netherlands
    ✭✭✭ National Healthcare Innovation Award ✭✭✭ Logica Innovation AwardCounselor to CEO, management team and program managers. Develop novel projects, funding and strategic collaborations.Examples: Prescription practices, Antibiotics & Resistance, International collaboration on rational use of medicin, Pharma chain development, Start & Stop apps (antidepressants, lungmedication, antibiotics, ADHD), Medication Safety, Healthcare for immigrants, Patient Empowerment, Immigrants, Improving the hospital patient status registration standards on pharmacotherapy.
  • Rivm National Institute For Public Health And The Environment
    Pertussis Vaccin Trial In Newborns, Bioterrorism
    Rivm National Institute For Public Health And The Environment Jun 2000 - Jun 2001
    Bilthoven
    GCP qualified project employee for Phase III clinical trial on newborns for a new pertussis (whooping cough) vaccine. A highly sensitive project under public attention. Knowledge management for central and field professionals, including central support, registration of adverse events (AE) and serious adverse events (SAE). Worked on bioterrorism threats and national responses, in particular on smallpox. Since smallpox officially had been eradicated, the population gradually lost it's immunity making it vulnerable to an outbreak. Developed in 'stealth mode'.
  • Universitair Medisch Centrum Utrecht
    Developer New Study Of Medicine At Utrecht University
    Universitair Medisch Centrum Utrecht 1999 - 2000
    Utrecht Area, Netherlands
    Project employee for the full scale modernization of the 6 year study of Medicine at Utrecht University.

Marco D'Agata Skills

Funding New Business Development Public Speaking Healthcare Project Management Proposal Writing Pharmacy Medicine Hospitals Management Clinical Trials Business Development Dutch Coaching Pharmaceutical Industry Strategy Policy Clinical Research Change Management Organizational Development Patient Safety

Marco D'Agata Education Details

Frequently Asked Questions about Marco D'Agata

What company does Marco D'Agata work for?

Marco D'Agata works for Neolook Solutions

What is Marco D'Agata's role at the current company?

Marco D'Agata's current role is CEO and Founder.

What is Marco D'Agata's email address?

Marco D'Agata's email address is ma****@****hmea.nl

What schools did Marco D'Agata attend?

Marco D'Agata attended Universiteit Utrecht, Rijkshogeschool Ijselland Deventer, Erasmus University Rotterdam.

What are some of Marco D'Agata's interests?

Marco D'Agata has interest in Social Services.

What skills is Marco D'Agata known for?

Marco D'Agata has skills like Funding, New Business Development, Public Speaking, Healthcare, Project Management, Proposal Writing, Pharmacy, Medicine, Hospitals, Management, Clinical Trials, Business Development.

Not the Marco D'Agata you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.